CD274 and non-small cell lung carcinoma: In present retrospective analysis, we investigated the clinical importance of PD-L1 expression in consecutive patients with unresectable stage III NSCLC treated with RT and ChT in our institution from 2012 to 2017 and correlated their expression with clinical characteristics, including patients’ outcomes.